Pharmaceutical manufacturer investing $5 million in capacity expansion
COLUMBIA, S.C. -- Alcami Corporation, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, today announced an investment of at least $5 million in the expansion of its existing Charleston County operations. This project is expected to lead to the creation of at least 30 new jobs.
Alcami offers a variety of biopharmaceutical services across active pharmaceutical ingredients, drug products (sterile, oral solid dose, packaging and labeling), development services and analytical testing. With six state-of-the-art locations in the United States and a seventh in the Netherlands, the company has supported more than 500 Investigational New Drug (IND) filings over the past 30 years.
Located at 4221 Faber Place Drive in North Charleston, S.C., Alcami will continue to expand its filling and freeze-drying capabilities. The site has recently produced clinical supply from its recently-qualified second line and doubled both its filling capacity and freeze-drying capacity with increased scheduling flexibility, including a third operating shift. Hiring for the new positions is already underway, and interested applicants should visit Alcami’s careers page online for more information.
QUOTES
“The Charleston facility is an integral part of the Alcami network. We are excited about the growth potential of the site and its ability to support the increased demand for sterile drug product development and manufacturing.” –Alcami CEO and President Stephan Kutzer
“To see a company like Alcami choose to continue investing in our state and our people is an important sign to the business community around the world that South Carolina is the place to be. We look forward to seeing the new heights the relationship between our state and this company will reach in the years to come.” –Gov. Henry McMaster
“We’re excited to celebrate the continued success of our state’s thriving manufacturing industry. I offer my congratulations to Alcami on this remarkable achievement and look forward to supporting them as they grow and prosper in our state.” –Secretary of Commerce Bobby Hitt
“Alcami’s announcement shows the community’s commitment and ability to compete in the life sciences sector and tap into this talent pipeline. We are elated by all their success and congratulate Alcami on their expansion.” –Charleston County Council Chairman Victor Rawl
“We always love to see new companies locate in North Charleston, but nothing tops seeing an existing company expand their operations within our city. Whether it be through company innovation, a capable workforce, or a business-friendly environment, local growth speaks volumes about our community. We congratulate Alcami on their expansion and look forward to future success here in North Charleston.” –North Charleston Mayor Keith Summey
“We are thrilled Alcami is injecting additional investment and jobs in our community. We look forward to our continued partnership.” –Charleston County Economic Development Director Steve Dykes
FIVE FAST FACTS
- Alcami Corporation is expanding its Charleston County operations.
- $5 million investment to create at least 30 new jobs.
- Alcami Corporation is a leading provider of custom manufacturing and development services for the pharmaceutical industry.
- Located at 4221 Faber Place Drive in North Charleston, S.C, the company will be expanding its filling and freeze-drying capabilities.
- Hiring for the new positions is already underway, and interested applicants should visit Alcami’s careers page online.
About Alcami
Alcami is a world-class contract development and manufacturing organization (CDMO) headquartered in Wilmington, North Carolina. With over 1,000 employees operating at seven sites globally, Alcami provides customizable and innovative services to small and mid-size pharmaceutical and biotechnology companies by offering individualized and integrated services across multiple areas. We connect our clients with innovative solutions for API development and manufacturing, solid-state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services. For more information, please visit www.alcaminow.com.